Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

In losing weight, Oprah Winfrey gained a new perspective ... she began using weight loss medications. In fact, Oprah recently detailed the ways in which using the drugs altered the way she ...

it has been barred by an old federal law from paying for weight-loss drugs. But last November Biden proposed new rules to allow Medicare and Medicaid to pay for these meds. The change would not ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...